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Abstract
 
Glucocorticoids (GCs) are important steroid hormones with widespread activities in metabo-
lism, development, and immune regulation. The adrenal glands are the major source of GCs
and release these hormones in response to psychological and immunological stress. However,
there is increasing evidence that GCs may also be synthesized by nonadrenal tissues. Here, we
report that the intestinal mucosa expresses steroidogenic enzymes and releases the GC corti-
costerone in response to T cell activation. T cell activation causes an increase in the intestinal
expression of the steroidogenic enzymes required for GC synthesis. In situ hybridization analysis
revealed that these enzymes are confined to the crypt region of the intestinal epithelial layer.
Surprisingly, in situ–produced GCs exhibit both an inhibitory and a costimulatory role on intestinal
T cell activation. In the absence of intestinal GCs in vivo
 
,
 
 activation by anti-CD3 injection resulted
in reduced CD69 expression and interferon-
 
 
 
 production by intestinal T cells, whereas activation
by viral infection led to increased T cell activation. We conclude that the intestinal mucosa is a
potent source of immunoregulatory GCs.
Key words: mucosal immunology • intraepithelial lymphocytes • costimulation • 
extraadrenal glucocorticoid synthesis • immune regulation
 
Introduction
 
The intestinal mucosa contains the largest number of immune
cells in our body, mainly to protect the enormous epithelial
surface that is responsible for the absorption of nutrients
and separates outside from inside. This extensive immune
system is not only in constant contact with harmless food
antigen and commensal bacteria but also with potentially
dangerous pathogenic bacteria, parasites, and viruses. Al-
though efficient intestinal immune responses protect the
host from invading pathogens, the inappropriate activation
of intestinal T cells may also result in chronic inflammatory
reactions and tissue destruction, e.g., as observed in inflam-
matory bowel disease (for review see reference 1). Thus, a
tight regulation of intestinal immune cells and their activation
is crucial to maintain tissue homeostasis and ensure protective
host defense. Several mechanisms that regulate intestinal
immune responses have been described. The intestinal mucosa
contains high levels of the immunosuppressive cytokines
TGF
 
 
 
 and IL-10 produced by the regulatory T cell subsets,
DCs, and even epithelial cells (2, 3). The importance of
these immunoregulatory cytokines in the maintenance of
immune homeostasis in the gut is illustrated by the fact that
TGF
 
 
 
 and IL-10–deficient mice develop spontaneous in-
flammatory bowel disease (for review see reference 1). In
addition, the presence of CD4
 
 
 
CD25
 
 
 
 regulatory T cells
has been reported in the intestinal mucosa, which can inhibit
the induction of experimental colitis by mechanisms yet to
be defined (4, 5). However, additional mechanisms may
exist to maintain locally confined and balanced immune re-
sponses in the intestinal mucosa.
Glucocorticoids (GCs) are lipid hormones playing an im-
portant role in the regulation of the immune system (for
review see reference 6). GCs are synthesized from choles-
terol via an enzymatic cascade (see Fig. 2 A), primarily in
the cortex of the adrenal glands. The inhibitory role of GCs
on immune cells is well characterized. For example, GCs
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potently inhibit the production of proinflammatory cytok-
ines, such as TNF
 
 
 
, presumably through the inhibition of
the transcription factors NF
 
 
 
B and AP-1 (7). The impor-
tance of this antiinflammatory action of GCs is well illus-
trated by the fact that GC inhibition or adrenalectomy re-
sults in a rapid septic shock and death upon systemic
immune stimulation (8, 9). Thus, as early as 1948 GCs and
other synthetic derivatives have been therapeutically used to
treat inflammatory diseases, including inflammatory diseases
of the intestine. Although the antiinflammatory activity of
GCs is well described, there is also accumulating evidence
that GCs are not only inhibitory, but may also enhance im-
mune cell activation and induce gene transcription (10, 11).
Adrenal glands synthesize and release GCs in enormous
quantities, i.e., upon induction by the pituitary gland–
released hormone ATCH (adrenocorticotropic hormone).
Recently, however, alternative sources of GCs have been de-
scribed. In particular, Ashwell and colleagues found that thy-
mic epithelial cells express the entire enzyme cascade required
for GC synthesis, enabling the release of bioactive GCs (12–
14). Thymocytes are exquisitely sensitive to GC receptor
(GR) activation and rapidly die by apoptosis. Although GCs
directly induce apoptosis, they also antagonize T cell recep-
tor–induced negative selection. Thus, thymic epithelium-
produced GCs have been implicated in the regulation of thy-
mic positive selection. However, the physiological role of
GCs in the thymus remains controversial (13, 15, 16).
Similar to the thymus, the expression of steroidogenic en-
zymes has also been described in the brain (17, 18). How-
ever, only adrenals and thymus have been found so far to
synthesize bioactive GCs from cholesterol. The intestinal
mucosa of fetal mice expresses steroidogenic enzymes (19).
Similarly, steroids were found to be synthesized in the small
intestine of frogs (20). In this study, we investigated whether
the intestinal mucosa is a source of GCs and the involve-
ment of intestinal GCs in the regulation of the local immune
system. We here show that upon T cell stimulation intestinal
epithelial cells express all steroidogenic enzymes required for
the synthesis of GCs and release the GC corticosterone. Our
results further support a regulatory role for in situ–produced
GCs in intestinal T cell activation. These findings define a
novel source of extraadrenal GC synthesis and shed new
light on GC-mediated immune regulation.
 
Materials and Methods
 
Cells and Reagents.
 
A1.1 T cell hybridoma cells have been
described previously (21). A1.1 were cultured in RPMI 1640,
supplemented with 5% FCS, 2 mM 
 
l
 
-glutamine, 100 U/ml pen-
icillin, 100 
 
 
 
g/ml streptomycin, 50 
 
 
 
M 
 
 
 
-mercaptoethanol, and
20 mM Hepes, pH 7.4. The murine epithelial cell line m-ICc12
was a gift of J.P. Kraehenbuehl (University of Lausanne, Lau-
sanne, Switzerland) and was cultured as described (22). Primary T
cells and mouse organs were cultured in IMDM containing 10%
steroid-free FCS, 2 mM 
 
l
 
-glutamine, 100 U/ml penicillin, 100
 
 
 
g/ml streptomycin, 50 
 
 
 
M 
 
 
 
-mercaptoethanol, and 20 mM
Hepes, pH 7.4. Steroid-free serum was prepared using dextran
T-70–coated Norit A charcoal as described previously (23).
Metyrapone and RU486 were from Sigma-Aldrich, and spirono-
lactone, pregnenolone, and corticosterone were from Acros Or-
ganics. Anti–mouse CD3
 
 
 
 (clone 145-2C11), B220, CD11c, and
MAC-1 were purified from hybridoma cell culture supernatant
using a protein A column. Anti–CD69-FITC, anti–TCR
 
 
 
-
FITC, anti–CD8
 
 
 
-Cy-chrome, anti–CD8
 
 
 
-PE, anti–CD4-PE,
and anti–
 
 
 
E
 
 
 
7-PE were obtained from BD Biosciences. Anti-
CD25 and anti-V
 
 
 
2 were from eBioscience, anti-P450 (ssc) was
from Chemicon, and anti–
 
 
 
-tubulin was from Sigma-Aldrich.
 
Detection of Corticosterone Synthesis in Intestinal Organ Cultures.
 
C57BL/6 mice (10–16 wk old) were breed and kept in the Cen-
tral Animal Facility of the Department of Medicine, University of
Bern. All animal experiments were performed in compliance
with the laws and guidelines of the State of Bern. To assess the
corticosterone synthesis in the intestinal mucosa or adrenal
glands, mice were injected with saline or 100 
 
 
 
g anti-CD3. After
4 h, mice were killed, serum was collected, and adrenal glands,
testes, liver, appendix, and small and large intestine were col-
lected for RNA isolation, in situ hybridization, or organ culture.
The entire small intestine was placed in cold Ca
 
2
 
 
 
/Mg
 
2
 
 
 
-free
HBSS containing 2% horse serum, Peyer’s patches were re-
moved, and the intestine was opened longitudinally and cut in
5-mm-long pieces. These were washed extensively in HBSS/2%
horse serum and then incubated for 10 min in HBSS/2% horse
serum containing 1 mM 1,4-dithiothreitol at 4
 
 
 
C to remove the
excess mucus. After additional washing in HBSS/2% horse se-
rum, tissue pieces were equally distributed in a 24-well plate and
incubated in IMDM containing 10% steroid-free FCS at 37
 
 
 
C.
The right and left adrenal gland were cut in half, and the right
half was incubated with the left half in a 24-well plate in steroid-
free medium. In some experiments, glucocorticoid synthesis was
blocked by addition of 200 
 
 
 
g/ml metyrapone to the organ cul-
ture. Metyrapone specifically blocks the activity of the two cor-
ticosterone-producing enzymes P450C11 and 11
 
 
 
-HSD1 (24,
25). After 4–5 h, cell-free supernatant was harvested and the cor-
ticosterone concentration was measured using a commercially
available radio-immuno assay kit (RIA; ICN). Metyrapone, at
the concentrations used (200 
 
 
 
g/ml), did not interfere with the
corticosterone assay (unpublished data). In some experiments, the
tissue volume was assessed after centrifugation in a graded tube.
 
Isolation of Intestinal Epithelial Cells.
 
Intestinal epithelial cells
from the small intestine of control or anti-CD3–injected animals
were isolated as described previously (26). Epithelial cells were
then further purified by cell sorting on a FACS Vantage (Becton
Dickinson), based on forward/side scatter properties and gating
out contaminating intraepithelial lymphocytes stained with anti-
CD4 and anti-CD8
 
 
 
. The purity of the preparations was found
to be 
 
 
 
98%.
 
Differential Isolation of Intestinal Epithelial Cells along the Villus-
Crypt Axis.
 
Intestinal epithelial cells were isolated following a
modified nonenzymatic method described by Traber et al. (27).
Briefly, the entire small intestine was placed in cold HBSS/2%
horse serum. Peyer’s patches were removed and the small intes-
tine was opened longitudinally, cut in 5–10-mm-long pieces, and
washed extensively in HBSS/2% horse serum. The tissue was
then incubated in HBSS/2% horse serum containing 1 mM DTT
for 10 min at 4
 
 
 
C to remove off the excess mucus. Afterwards,
tissue pieces were incubated in HBSS/2% horse serum containing
2 mM DTT and 0.5 mM EDTA for 2 min at 37
 
 
 
C under stirring
conditions. The detached cells were collected and referred to as
fraction 1. Fractions 2–10 were generated by the same procedure
over nine cycles with time intervals of 2, 2, 2, 2, 5, 5, 5, 10, and
10 min. Cells from each fraction were washed and further pro-
cessed for total RNA or protein isolation. Alkaline phosphatase is 
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expressed in the villus epithelial cells but not in the crypt cells. To
validate the isolation procedure, endogenous alkaline phosphatase
activity was assessed by incubating 20 
 
 
 
g protein of each fraction
with p-nitrophenyl phosphate as substrate and measurement of
OD 405 nm. To visualize endogenous alkaline phosphatase in
small intestinal tissue, 5-
 
 
 
m frozen sections were fixed in ace-
tone, incubated with alkaline phosphatase substrate, and counter-
stained with hematoxylin and eosin.
 
Detection of Gene Products of Steroidogenic Enzymes by RT-
PCR.
 
Sorted epithelial cells or frozen tissue was lysed in RNA
isolation reagent (TRI-reagent; Sigma-Aldrich), and RNA was
isolated according to manufacturer’s protocol. Total RNA was
DNase treated to remove genomic DNA and reverse transcribed
using a commercially available kit (Promega). The PCR reaction
mixture consisted of 37.85 
 
 
 
l nuclease-free water, 5 
 
 
 
l 10
 
 
 
 re-
action buffer, 1 
 
 
 
l dNTPs (10 
 
 
 
M), 2U Taq polymerase, 0.25 
 
 
 
l
of each primer (100 
 
 
 
M), 1.25 
 
 
 
l of MgCl
 
2
 
 (50 mM) (all from
Invitrogen), and 4 
 
 
 
l cDNA (50 ng/
 
 
 
l). The following amplifi-
cation parameters were used: actin: 1 min at 95
 
 
 
C, 1 min at
55
 
 
 
C, and 1 min at 72
 
 
 
C for 20 cycles; CYP11A1 and CYP21: 1
min at 95
 
 
 
C, 1 min at 60
 
 
 
C, and 1 min at 72
 
 
 
C for 38 cycles;
CYP11B1: 1 min at 95
 
 
 
C, 1 min at 55
 
 
 
C, and 1 min at 72
 
 
 
C for
40 cycles; HSD11B1 and HSD3B1: 1 min at 95
 
 
 
C, 1 min at
55
 
 
 
C, and 1 min at 72
 
 
 
C for 35 cycles. All amplifications in-
cluded a final extension of 10 min at 72
 
 
 
C and were performed in
a Biometra T3 Thermocycler (Whatman Biometra). The primers
used were: 
 
 
 
-actin forward, 5
 
 
 
-TGGAATCCTGTGGCATCC-
ATGAAAC-3
 
 
 
, and reverse, 5
 
 
 
-TAAAACGCAGCTCAGTAA-
CAGTCCG-3
 
 
 
; mouse CYP11A1 forward, 5
 
 
 
-CCAGGCCA-
ACATTACCGAGAT-3
 
 
 
, and reverse, 5
 
 
 
-GACTTCAGCCC-
GCAGCAT-3
 
 
 
; mouse CYP21 forward, 5
 
 
 
-AACCACTGGTC-
CATCCAAATCT-3
 
 
 
, and reverse, 5
 
 
 
-TCTTCGTCTTTGC-
CATCCCT-3
 
 
 
; mouse HSD3B1 forward, 5
 
 
 
-AATCTGAAAG-
GTACCCAGAA-3
 
 
 
, and reverse, 5
 
 
 
-CTCAGGGTGCAATT-
TAAATC-3
 
 
 
; mouse CYP11B1 forward, 5
 
 
 
-CCATAGAAG-
CTAGCCACTTGT-3
 
 
 
, and reverse, 5
 
 
 
-GGGTTGATGTC-
GTGTCAGT-3
 
 
 
; mouse HSD11B1 forward, 5
 
 
 
-TCTCGTGC-
CTTGAACTCG-3
 
 
 
, and reverse, 5
 
 
 
-CCTTGGTTATGTAGA-
GTTCTG-3
 
 
 
. PCR products were separated on a 4% polyacryla-
mide-Tris-borate-EDTA gel and stained with ethidium bromide.
The correct amplification of CYP11A1, CYP11B1, and
HSD11B1 was confirmed by sequencing.
CYP11A1 expression was also assessed by real-time PCR using
the above described CYP11A1 primers and SYBR green mix
(Applied Biosystems). DNA was amplified on an ABI prism 7700,
and the increase in gene expression was calculated using the Se-
quence Detection System 1.7 software (Applied Biosystems).
 
In Situ Hybridization.
 
The PCR products of CYP11A1,
CYP11B1, and HSD11B1 were cloned into the pGEM-T-easy
vector (Promega), sequenced, and used to prepare 
 
35
 
S-labeled an-
tisense and sense RNA probes as described previously (28). 5-
 
 
 
m
cryostat sections on poly-
 
l
 
-lysine slides were fixed in PBS/4%
paraformaldehyde for 20 min, washed in PBS and H
 
2
 
O, and de-
hydrated in an ethanol row. Sections were then hybridized with
the probes at a concentration of 2 
 
 
 
 10
 
5
 
 cpm/
 
 
 
l in hybridization
solution as described previously (28). After overnight hybridiza-
tion, nonhybridized probe was removed by washing, slides were
dipped in NTB-2 emulsion (Eastman Kodak Co), 1:2 diluted in
800 mM ammonium acetate, and exposed in the dark at 4
 
 
 
C for
3 wk. Then, slides were developed using Kodak PL 12 devel-
oper, fixed, and counterstained with nuclear fast red.
 
Detection of P450 (ssc) by Western Blot.
 
Purified epithelial
cells, intestinal tissue, or adrenal glands were solubilized in RIPA
buffer (150 mM NaCl, 10 mM Tris, 0.1% SDS, 1% Triton
X-100, 1% deoxycholate, 5 mM EDTA) plus protease inhibitors
(1 mM phenylmethylsulfonyl fluoride, 10 mM benzamidine, 2
 
 
 
g/ml leupeptin). 20 
 
 g of protein were resolved on a 12%
SDS-PAGE and blotted on nitrocellulose. P450 (ssc) was detected
using a polyclonal rabbit anti–rat P450 (ssc) antibody and goat
anti–rabbit peroxidase conjugate (Bio-Rad Laboratories). Equal
protein loading was confirmed by the detection of  -tubulin.
Adrenalectomy and In Vivo T Cell Activation. Mice were anes-
thetized by i.p. injection of ketamine (100 mg/kg body weight)
and xylazine (10 mg/kg body weight), and adrenal glands were
removed as previously described (29). Animals were given 0.9%
NaCl and 5% glucose in drinking water ad libitum and were al-
lowed to recover for 10 d before the experiment. At this point,
the removal of the adrenal glands was confirmed by the absence
of serum corticosterone as assessed by RIA. In addition, after the
experiments the periadrenal fat was visually examined to verify
complete removal of the adrenals.
To assess the role of intestinal corticosterone in the regulation
of intestinal T cells, mice were treated with saline or 100 mg
metyrapone/kg body weight by i.p. injection for 1 h before in-
jection of saline or 50  g anti-CD3. A single dose of metyrapone
has been shown previously to completely block GC synthesis in
vivo (30). After 3 h, mice were killed. Serum was collected and
analyzed for the absence of corticosterone release. Peyer’s patches
were removed from the small intestine, and lymphocyte suspen-
sion was prepared by physical dissociation between frosted slides.
Intraepithelial lymphocytes (IELs) were prepared from the re-
maining small intestinal tissue by Percoll density gradients as de-
scribed previously (26, 31). Isolated cells were resuspended in
IMDM with 10% steroid-free serum for further analysis. The ex-
perimental procedure is summarized in a flow chart in Fig. 4 A.
Viral Infection of Adrenalectomized Mice. TCR transgenic (tg)
mice, specific for the gp33-41 (gp33) peptide of lymphocytic
choriomeningitis virus (LCMV) (line 318), were adrenalecto-
mized and subsequently infected with 2   104 pfu LCMV strain
WE by i.p. injection (32). At 0, 8, and 16 h after viral infection,
mice were injected i.p. with 50 mg metyrapone per kg body
weight or control vehicle. After 30 h, mice were killed and intes-
tinal lymphocytes were isolated as described above. The experi-
mental procedure is summarized in a flow chart in Fig. 5 A.
Flow Cytometry. IELs were stained with anti-CD8  and anti-
CD8  to distinguish between CD8   and CD8   IELs. Peyer’s
patch lymphocytes (PPLs) were stained with anti-CD4 and anti-
CD8. The in vivo activation of all T cell subsets was then assessed
by counterstaining with anti-TCR  or anti-CD69. After wash-
ing, cells were fixed in 4% paraformaldehyde in PBS and analyzed
on a FACScan flow cytometer using Cell Quest software (Becton
Dickinson). Electronic gates were drawn around the lymphocyte
population, and TCR and CD69 expression was assessed on indi-
vidual T cell subsets. The presence of dendritic cells was excluded
by staining with anti-CD11c. TCR tg T cells (V 2/V 8) were
detected by staining with anti-V 2 antibody
Ex Vivo IFN  Production. PPLs were cultured for 16 h at 6  
106/ml in steroid-free medium in 24-well plates followed assess-
ment of IFN  production by ELISA (R&D Systems).
In Vitro T Cell Activation. A1.1 T cells were cultured at
100,000 cells/well on anti-CD3–coated 96-well plates for various
time intervals. T cell activation was modified by 30 min prein-
cubation with various concentrations of corticosterone, preg-
nenolone, or metyrapone, and assessed by CD69 staining as de-
scribed above. The glucocorticoid receptor was blocked by
addition of RU486, and the mineralocorticoid receptor was in-Glucocorticoid Synthesis by Intestinal Epithelial Cells 1638
hibited by spironolactone. Cell viability was assessed by annexin
V staining (31), and only viable cells were analyzed.
Alternatively, splenic T cells were isolated from WT C57Bl/6
mice or TCR tg mice. Briefly, splenocytes were depleted from
B220 , CD11c , and MAC-1  cells by MACS according to
manufacturer’s instruction (Miltenyi Biotec). The resulting T cell
fraction was always  94% CD3 . T cells were either stimulated
with plate-bound anti-CD3 (4  g/ml) or irradiated C57Bl/6
spleen cells pulsed previously with 100 ng/ml gp33 peptide or
adn5 control peptide (32), in the presence or absence of various
concentrations of corticosterone. Cell activation and IFN  pro-
duction was assessed as described above.
Accession Numbers. Sequence data is available for the follow-
ing genes from GenBank/EMBL/DDBJ:mouse CYP11A1, ac-
cession no. AF19511; mouse CYP21, accession no. M15009;
mouse HSD3B1, accession no. M58567; and mouse HSD11B1,
accession no. S75207.
Statistical Analyses. Data are expressed as mean   SD. Statis-
tical differences were analyzed by two-tailed unpaired Student’s t
test with unequal variances.
Results
Detection of Corticosterone Production in the Small Intestinal
Mucosa of Immune-stimulated Mice. Corticosterone is the
most abundantly produced and bioactive GCs in rats and
mice and crucially involved in the regulation of immune
cells and their responses. Thus, we aimed at analyzing the
corticosterone production in the intestinal mucosa of mice.
For this purpose, we obtained small intestinal tissue from
C57Bl/6 mice for subsequent ex vivo culture in steroid-
free medium for 4–5 h and analysis of corticosterone syn-
thesis by RIA. However, only minimal corticosterone lev-
els were detected in the cell-free culture supernatant.
Therefore, we hypothesized that GC production by the in-
testinal mucosa may only be induced upon immune cell
stimulation. Subsequently, mice were injected with saline
or anti-CD3 antibody for 4 h, and ex vivo corticosterone
synthesis in isolated small intestinal tissue was assessed. Fig.
1 A shows that although only minimal corticosterone was
released from intestinal tissue of control mice, considerable
amounts of corticosterone were secreted from small intes-
tine of anti-CD3–stimulated mice. These elevated levels of
corticosterone were the result of in situ glucocorticoid
synthesis and not due to serum GC contamination since
metyrapone, a potent inhibitor of corticosterone synthesis
(24, 25), blocked both corticosterone release from small in-
testinal tissue (Fig. 1 A) and from in vitro–cultured adrenal
glands (Fig. 1 C). To get an estimate of the steroid-produc-
ing capacity of intestinal tissue, we also assessed the total
amount of corticosterone produced per cm3 intestinal tis-
sue. Fig. 1 B shows that the small intestinal mucosa synthe-
sized  0.75 ng corticosterone per 0.1 cm3 tissue. This cor-
responds to  25 nM corticosterone, a concentration which
has been reported to be biologically active, i.e., induction
of nuclear translocation of the GR (33) and T cell prolifer-
ation (34). Thus, we conclude that the small intestinal mu-
cosa is a potent source of GCs.
Expression of Steroidogenic Enzyme Genes in the Intestinal
Mucosa. The results described above support the idea that
GCs are produced in situ. Subsequently, all enzymes re-
quired for the biosynthesis of corticosterone from choles-
terol (Fig. 2 A) must be expressed within the intestinal mu-
cosa. Thus, the steroidogenic enzyme expression in adrenal
glands, small and large intestine, appendix, and liver from
control mice or anti-CD3–injected animals was analyzed by
RT-PCR (Fig. 2 B). As expected, CYP11A1, HSD3B1,
CYP21, CYP11B1, and HSD11B1, i.e., the genes of the
steroidogenic enzymes involved in corticosterone synthesis,
were found to be expressed within the adrenal glands. In
the different parts of the intestine (small and large intestine
and appendix) some genes were expressed in a constitutive
manner, whereas others were specifically detected only in
anti-CD3–injected animals. In particular, the rate-limiting
enzyme CYP11A1 (P450 ssc) was not detected in the intes-
tinal tissue and liver of control mice but became induced in
the intestine in response to T cell activation. This data was
confirmed using quantitative real-time RT-PCR. Fig. 2 C
illustrates that in the different sections of the small intestine
(proximal, middle, and distal) and in the large intestine the
expression of CYP11A1 was strongly up-regulated in re-
sponse to anti-CD3 injection but failed to be induced in
the liver. This observation is in agreement with our finding
that ex vivo cultured liver tissue did not release metyrapone-
blockable corticosterone (unpublished data). The presence
and increased expression of the CYP11A1 gene product
P450 (ssc) in anti-CD3–treated small intestine was also con-
firmed by Western blot (Fig. 2 D).
Figure 1. Corticosterone synthesis by the in-
testinal mucosa. (A) Small intestinal tissue from
control mice (unstim.) or anti-CD3–injected
mice ( CD3) were cultured ex vivo for 5 h in
the presence or absence of metyrapone. Corticos-
terone in the cell-free supernatant was measured
by RIA. (B) Presentation of the data shown in A
as ng corticosterone per 0.1 cm3 small intestinal
tissue. Mean values of triplicates of a typical exper-
iment out of five are shown. An asterisk indicates
P   0.05 as assessed by the unpaired Student’s t
test. (C) Isolated adrenal glands were cultured
with control medium or metyrapone (met.) for
5 h, and corticosterone released into the super-
natant was assessed by RIA. A typical experi-
ment out of four is shown.Cima et al. 1639
Intestinal Epithelial Cells Express Steroidogenic Enzymes.
To identify the cellular source of GCs, we performed in situ
hybridization for the three most crucial enzymes of the
biosynthesis of corticosterone, i.e., CYP11A1 (P450 ssc),
converting cholesterol to pregnenolone and CYP11B1
(P450C11) and HSD11B1 (11 -HSD1), synthesizing bio-
active corticosterone from 11-deoxycorticosterone and 11-
dehydrocorticosterone, respectively (Fig. 2 A). Tissue sections
of adrenal gland, testis, and small intestine from anti-
CD3–injected animals were hybridized with radiolabeled an-
tisense probes or CYP11B1 sense probe as negative control.
Fig. 3 A shows that mRNAs for all enzymes were abundantly
expressed in the cortex of the adrenal glands, confirming the
specificity of the probes. In the testis, only CYP11A1 expres-
sion, but not CYP11B1 and HSD11B1, was detected in Ley-
dig cells. This finding is in agreement with the important role
of the testis in sex hormone (e.g., testosterone) but not GC
synthesis. Importantly, however, mRNAs of all three enzymes
(CYP11A1, CYP11B1, and HSD11B1) were clearly detected
in the crypt region of the small intestine (Fig. 3 A). CYP11A1
appeared to be expressed most abundantly, whereas CYP11B1
and HSD11B1 were expressed at lower but still clearly detect-
able levels. No signals were detected with the sense control.
This finding supports the idea that intestinal epithelial
cells, and probably more specifically crypt cells, might be
the source of these enzymes. Therefore, we isolated and
sorted epithelial cells from control and anti-CD3–injected
animals by flow cytometry to high purity and analyzed the
expression of CYP11A1, CYP11B1, and HSD11B1 by
RT-PCR. In agreement with the in situ hybridization
(Fig. 3 A) and RT-PCR from total tissue (Fig. 2, B and C),
we found all three enzymes expressed in the epithelial cells
from anti-CD3–injected animals (Fig. 3 B). Importantly,
mRNAs of CYP11A1, CYP11B1, and HSD11B1 were also
detected in the murine intestinal crypt cell line m-Icc12
(22), confirming that intestinal epithelial cells express ste-
roidogenic enzymes. mRNA of all three genes were also
found in human colonic tissue, isolated human colonic ep-
ithelial cells, and the colonic epithelial cell lines CaCo2 and
T84 (unpublished data), further supporting a role of intesti-
nal epithelial cells in the production of GCs.
To further investigate the role of crypt cells as the source
of steroidogenic enzymes, we analyzed CYP11A1 RNA
expression and P450 (ssc) protein expression in differen-
tially isolated epithelial cells. Whereas villus epithelial cells
express endogenous alkaline phosphatase, crypt cells lack
the expression of this marker (Fig. 3 C). Differential isola-
tion of epithelial cells from the villus top to the crypts
shows a gradual decrease of alkaline phosphatase activity in
the different fractions (Fig. 3 D), confirming the alkaline
Figure 2. Detection of steroidogenic enzyme expression
in intestinal tissue. (A) A simplified scheme of the biosyn-
thesis pathway from cholesterol to corticosterone. The
protein and gene names of the enzymes involved in the
specific biosynthesis steps are boxed. (B) Adrenal glands,
small and large intestine, appendix, and liver from control
mice or anti-CD3–injected mice were isolated, and gene
expression of steroidogenic enzymes was assessed by RT-
PCR. Equal loading was controlled by amplification of actin.
A typical experiment out of four is shown. (C) Detection
of CYP11A1 expression in different sections of the small
intestine (proximal [prox.], middle [mid.], distal [dist.]),
the large intestine, and the liver by quantitative real-time
RT-PCR. A typical experiment out of two is shown.
(D) Detection of P450 (ssc) protein. Protein extracts from
adrenal gland (positive control) or small intestine from
control or anti-CD3–treated mice were assessed for P450
(ssc) expression by Western blot. Equal protein loading
was confirmed by the detection of tubulin. Adr., adrenal
glands; Contr., control.Glucocorticoid Synthesis by Intestinal Epithelial Cells 1640
phosphatase expression pattern shown in Fig. 3 C. When
the different fractions were analyzed for CYP11A1 mRNA
expression (Fig. 3 E) or P450 (ssc) protein expression (Fig.
3 F), it revealed that this enzyme is predominantly ex-
pressed by alkaline phosphatase-negative crypt cell frac-
tions. Thus, these data confirm the crypt cells as the source
of intestinal glucocorticoids.
In Situ–produced GCs Regulate Intestinal T Cell Activation.
GCs have been proposed to mediate both inhibitory and
stimulating activities in immune cells (for review see refer-
ence 10). We next analyzed the role of in situ–produced
GCs on the activation of resident intestinal T cells by per-
forming the following experiment (Fig. 4 A). Mice were
adrenalectomized to exclude a contribution of systemic
GCs released by the adrenal glands. After 10 d recovery pe-
riod, serum GC levels were analyzed to confirm the suc-
cessful removal of the glands. Then, mice were either in-
jected with saline or with metyrapone to inhibit de novo
GC synthesis and 1 h later with saline or anti-CD3 to acti-
vate T cells. Previous experiments have shown that a single
Figure 3. Localization of steroidogenic
enzyme expression in small intestinal crypt
cells. (A) In situ hybridization for ste-
roidogenic enzymes. Tissue sections from
small intestine, adrenal glands, and testis
were hybridized with radiolabeled anti-
sense probes for CYP11A1, CYP11B1,
and HSD11B1. Unspecific binding was
controlled using the CYP11B1 sense
probe. M, muscularis; Cr, crypts; V, villi;
C, cortex; Me, medulla; L, Leydig cells; S,
Sertoli cells. A typical experiment out of
two is shown. (B) Detection of ste-
roidogenic enzyme expression in isolated
epithelial cells. CYP11A1, CYP11B1,
HSD11B1, and actin expression in adrenal
glands (Adr.), isolated epithelial cells from
control (contr.) and anti-CD3–injected
mice ( CD3), or the murine epithelial
crypt cell line m-ICc12 was assessed by RT-PCR. (C) Detection of endogenous alkaline phosphatase on small intestinal tissue sections. The luminal site
of the epithelial layer stains red for alkaline phosphatase activity, whereas crypt cells are negative. V, villus; Cr, crypts; M, muscularis. (D) Analysis of al-
kaline phosphatase activity in differentially isolated epithelial cell fractions. Fraction 3 corresponds to the top villus fraction; fraction 10 corresponds to
the bottom crypt cell fraction. (E) Analysis of CYP11A1 mRNA expression in the different epithelial cell fractions by RT-PCR. Equal amounts of
RNA were confirmed by the detection of actin mRNA. (F) Detection of P450 (ssc) protein in the different epithelial cell fractions by Western blot.
Equal protein loading was confirmed by the detection of tubulin.Cima et al. 1641
dose of metyrapone leads to significant in vivo inhibition of
P450C11 and 11 -HSD1 and, therefore, specifically blocks
GC synthesis (30, 35). After an additional 3 h, mice were
killed, and we assessed GC levels in the serum and the acti-
vation status of intestinal T cells. Fig. 4 B clearly shows that
although sham-operated mice had high GC levels in the se-
rum after anti-CD3 injection, adrenalectomized mice failed
to release GCs, demonstrating the efficient removal of sys-
temic GCs. This finding also excludes that GCs produced
in other organs than the intestine may be transported to the
intestine via the serum.
One of the early activation markers in T cells is the
down-regulation of the T cell receptor and the up-regula-
tion of CD69. We next analyzed these two parameters in T
Figure 4. In situ–produced GCs regulate intestinal
T cell activation in vivo. (A) Schematic overview of
the in vivo experiments. Mice were adrenalectomized
to remove the major source of systemic GCs. After 10 d
recovery, animals were pretreated for 1 h with saline
or metyrapone before injection of saline or anti-CD3
to activate T cells in vivo. After 3 h, GCs in the serum
and the activation status of intestinal T cells were
assessed. (B) Adrenalectomized animals fail to secrete
GCs into the serum upon immune stimulation.
Control mice (sham) or adrenalectomized animals
were treated with saline (contr.) or anti-CD3, and
corticosterone levels in the serum were assessed after
3 h (mean values   SD of six mice per group).
(C) Animals were treated as shown in A. IELs and
PPLs were isolated and TCR   and CD69 expres-
sion on the CD8   and CD8   subsets (IEL), or
CD69 expression on CD4  and CD8  T cells
(PPL), was monitored by flow cytometry. A typical
experiment out of four is shown. Numbers indicate
mean values of the percentage of positive cells in
the indicated gates of three animals per group. An
asterisk indicates a p-value of  0.05 for  CD3 vs.
 CD3  metyrapone. Note that TCR    in the
CD8    IEL population are TCR    T cells.
(D) Animals were treated as indicated in A. PPLs
from control-, metyrapone- (met.), anti-CD3– or
metyrapone plus anti-CD3–treated animals were
isolated and cultured overnight. IFN  in the cell-
free supernatant was analyzed by ELISA. Bullets in-
dicate values obtained with cells from individual
animals (n   6 per group), horizontal bars indicate
mean values, and the asterisk indicates P   0.05.Glucocorticoid Synthesis by Intestinal Epithelial Cells 1642
cells from two distinct intestinal compartments, i.e., IELs
and PPLs, of mice treated with or without metyrapone,
and with or without anti-CD3. Fig. 4 C shows that anti-
CD3 injection caused a strong activation signal in the
CD8   and CD8   IEL subsets and in PPLs. Although
the TCR   of these intestinal T cells was clearly
down-regulated, CD69 expression was strongly up-regu-
lated. Based on the percentage and absolute numbers
of bona fide CD8     E 7  IELs, no infiltration of acti-
vated peripheral T cells could be detected during the ob-
servation period (unpublished data). Thus, we conclude
that anti-CD3 injection led to the local activation of IELs
and PPLs. Surprisingly, inhibition of GC synthesis by the
treatment of the mice with metyrapone did not cause an
increase in T cell activation but resulted in significantly re-
duced cell activation. Importantly, no increase in T cell
death was observed during the observation period, exclud-
ing the possibility that metyrapone may be toxic to intesti-
nal T cells (unpublished data). Many CD8    IELs express
the TCR   (CD8    TCR    IELs in Fig. 4 C). Simi-
larly to the TCR    IELs, anti-CD3–induced TCR  
down-regulation was reduced upon metyrapone treatment
(unpublished data).
This finding was also confirmed when the IFN  produc-
tion of in vivo–stimulated and ex vivo–cultured PPLs was
analyzed. Although cells from control mice or metyrapone-
Figure 5. In situ–produced
GCs inhibit the activation of virus-
specific intestinal T cells. (A) Sche-
matic overview of the in vivo
experiments. TCR tg mice were
adrenalectomized to remove the
major source of systemic GCs.
After 10 d recovery, animals were
treated with saline or metyrapone
before infection with LCMV.
Metyrapone or saline treatment
was repeated after 8 and 16 h. 30 h
postviral infection, the activa-
tion status of intestinal T cells
were assessed. (B) Animals were
treated as shown in A. IELs, PPLs,
and mesentheric lymph node cells
(MLNCs) were isolated. CD69
expression on the TCR tg T cells
(V 2 ) on CD8   and CD8  
subsets (IEL), or CD69 expres-
sion on the TCR tg T cells on
CD8  T cells (PPL, MLNC) was
monitored by flow cytometry.
A typical experiment is shown
(n   3 per group; two experi-
ments). Numbers indicate p-values
of the Student’s t test. (C) Ani-
mals were treated as described
in A. IELs, PPLs, and MLNCs
from LCMV-infected or LCMV-
infected and metyrapone-treated
(Met.) were isolated and cultured
overnight. IFN  in the culture su-
pernatant was assessed by ELISA.
Numbers indicate p-values.Cima et al. 1643
injected mice failed to synthesize IFN , a strong increase in
cytokine production was observed in cells from anti-CD3–
injected animals. In contrast, only minimal IFN  was re-
leased by PPLs isolated from metyrapone-treated and anti-
CD3–injected animals. These data support the idea that in
situ produced GCs regulate intestinal T cell activation in a
positive manner.
Inhibitory Role of Intestinal GCs on Virus-induced Intestinal
T Cell Activation. Since GCs have been predominantly re-
ported to exhibit an inhibitory activity on the activation of
antigen-specific T cells, the role of intestinal GCs was fur-
ther analyzed in a virus infection model. TCR tg mice, spe-
cific for the LCMV peptide gp33 (32), were adrenalecto-
mized, treated with metyrapone or control vehicle, and
subsequently infected with LCMV (Fig. 5 A). Again, intesti-
nal T cell activation was assessed by the detection of the acti-
vation marker CD69 and the generation of IFN  ex vivo.
LCMV infection resulted in a clear induction of CD69
expression in all intestinal T cells analyzed (i.e., CD8   
IELs, CD8    IELs, CD8  PPLs, and CD8  mesentheric
lymph node cells). Surprisingly, however, inhibition of in-
testinal GC synthesis resulted in a significantly increased T
cell activation, as demonstrated by increased numbers of
CD69  T cells (Fig. 5 B). This increased intestinal T cell
activation was also confirmed by an elevated IFN  produc-
tion by ex vivo cultured intestinal T cells isolated from
LCMV-infected and metyrapone-treated mice (Fig. 5 C).
Thus, in contrast to intestinal T cell activation by anti-CD3
injection, locally produced GCs exhibit an inhibitory role
on the activation of intestinal T cells upon viral infection.
Corticosterone Synergistically Enhances Anti-CD3–mediated
T Cell Activation In Vitro. GCs are primarily known for
their inhibitory action on immune cell activation. Al-
though stimulatory effects of GCs have also been described,
particularly at lower concentrations (10), the enhancing ef-
fect of in situ produced intestinal GCs on anti-CD3–
induced T cell activation, but inhibitory role on virus-
induced T cell activation, was surprising. Thus, we aimed
at further characterizing this paradoxical role of GCs on T
cell activation in vitro. We first investigated the costimula-
tory role of GCs on the anti-CD3–induced activation of
the T cell hybridoma A1.1 (21). A1.1 cells were stimulated
with plate-bound anti-CD3 in the presence or absence of
corticosterone, and CD69 expression was analyzed by flow
cytometry. Fig. 6, A and B, illustrates that T cell activation
caused a significant increase in CD69 expression, which
was further enhanced by the addition of corticosterone.
This costimulatory effect of corticosterone was found to be
dose dependent (Fig. 6 B). In contrast, metyrapone, at con-
centrations that blocked corticosterone synthesis in adrenal
glands and intestinal tissue (Fig. 1), did not modulate anti-
CD3–induced CD69 expression (Fig. 6 B), ruling out an
unspecific effect of metyrapone on intestinal T cell activa-
Figure 6. Corticosterone synergistically enhances anti-CD3–induced T
cell activation. (A) A1.1 T cells were left untreated or stimulated with
anti-CD3 in the presence or absence of corticosterone. Cells were then
stained with isotype control (shaded histogram) or anti-CD69 (empty his-
tograms). Fluorescence was analyzed by flow cytometry. (B) A1.1 cells
were treated with different concentrations of corticosterone or metyrapone
before stimulation with anti-CD3. CD69 expression was assessed by flow
cytometry. Mean values of CD69 expression (mean fluorescence intensity
[MFI]) of triplicates   SD are shown. (C) Time course (0–6 h) of CD69
induction in control- or corticosterone-treated and anti-CD3–stimulated
cells. Numbers indicate the percentage of positive cells in the gate. (D) A1.1
cells were pretreated with corticosterone (Cort.; 100 nM), RU-486 (1  M),
spironolactone (Spiro; 1  M) or pregnenolone (Preg.; 1  M) before
stimulation with medium control or anti-CD3 for 6 h. Mean values of
CD69 MFI of triplicates   SD are shown. *P   0.05; n.s., not significant.
All experiments were repeated at least three times.Glucocorticoid Synthesis by Intestinal Epithelial Cells 1644
again the same results as obtained in vivo. Anti-CD3–
induced CD69 expression was enhanced by increasing con-
centrations of corticosterone, whereas peptide-induced acti-
vation was clearly inhibited (Fig. 7 A). Similar findings were
obtained when analyzing IFN  production (Fig. 7 B). Anti-
CD3–induced cytokine production was enhanced with cor-
ticosterone, whereas antigen-induced IFN  was inhibited.
Both the costimulatory and the inhibitory effect of corticos-
terone on CD69 expression and IFN  production was me-
diated via the GR since it was blocked by the addition of
the GR antagonist RU486 (Fig. 7, A and B).
Discussion
Steroid hormones are crucially involved in the regulation
of various physiological and pathophysiological processes,
such as metabolism, development, reproduction, and im-
mune responses (for review see reference 10). In particular,
the importance of GCs produced by the adrenal glands in
response to stress or immune stimulation has been recog-
nized for decades. In the target cell, GCs bind to the GR,
and upon translocation to the nucleus, may inhibit the tran-
scription of proinflammatory cytokines, such as IFN ,
TNF , IL-1 , IL-6, IL-8, and IL-12 (10, 11). Therefore,
GCs blunt overly aggressive immune responses and may
prevent subsequent serious damage to the host. This immu-
noregulatory role of adrenal-derived GCs on systemic im-
mune responses has been clearly demonstrated by Gonzalo
and colleagues, who showed that adrenalectomy or inhibi-
tion of the GR results in lethal septic shock upon systemic T
cell activation (8). Similarly, endogenous GCs protect against
cytokine-mediated lethality during viral infection (9).
Much to our surprise, we have made the paradoxical ob-
servation that GCs have a costimulatory effect on anti-
CD3–induced activation of T cells but inhibit T cell acti-
vation by antigen presentation in vivo and in vitro. Thus,
depending on the mode of activation GCs have both co-
stimulatory and inhibitory activities on T cell activation. Since
anti-CD3 ligation represents a direct activation mechanism
independent of accessory cells, GCs may enhance T cell ac-
tivation by potentially replacing the costimulatory second
signal usually provided by B7-CD28 interaction. In line of
this notion are reports that demonstrate elevated induction
of secondary intracellular mediators in the presence of GCs
(36). When T cells are activated by APCs, this costimula-
tory activity of GCs on T cell activation may not be re-
quired anymore for full activation, but instead GCs may
have an inhibitory activity on the APC and subsequently
on the T cell activation. It is thus interesting to note that
GCs have potent inhibitory effects on the expression of co-
stimulatory cytokines and cell surface molecules (10, 11).
It is very likely that this costimulatory effect of endoge-
nous GCs on T cell activation is not mediated by the regu-
lation of gene expression but rather based on posttransla-
tional signal modifications (37). Both the in vivo and in
vitro activation of T cells and the costimulation by corticos-
terone were very rapid. In vivo, we observed reduced
TCR down-regulation and CD69 expression in the absence
Figure 7. Differential activity of corticosterone on anti-CD3 or peptide-
activated T cells. (A) T cells from TCR tg mice were isolated and either
stimulated with plate-bound anti-CD3 or gp33 peptide-pulsed irradiated
spleen cells (antigen). Corticosterone at different concentrations or the
GR antagonist RU486 were added at the beginning of the experiment.
After overnight culture, CD69 expression (MFI) on V 2  CD8  cells
(TCR tg T cells) was assessed by flow cytometry. Experiments were per-
formed in triplicates. *P   0.05; **P   0.005. (B) T cells were activated
as described above, and IFN  production was analyzed after 48 h. *P  
0.05. A typical experiment out of three is shown.
tion in vivo. Interestingly, costimulation with corticos-
terone not only resulted in a stronger T cell activation but
also in a faster kinetic of CD69 expression than observed in
cells stimulated with anti-CD3 only (Fig. 6 C).
Costimulation by corticosterone was clearly mediated by
the GR since the GR antagonist RU486 but not the min-
eralocorticoid receptor antagonist spironolactone blocked
the corticosterone-mediated increase in CD69 expression.
No effect was seen with pregnenolone, a precursor in the
GC biosynthesis pathway (Fig. 6 D).
Differential Effects of Corticosterone on Anti-CD3–induced
versus Antigen-induced T Cell Activation. To further investi-
gate this costimulatory versus inhibitory effect on anti-
CD3–induced versus antigen–induced T cell activation,
TCR tg T cells were either stimulated with plate-bound
anti-CD3 or gp33 peptide-pulsed irradiated spleen cells. In-
terestingly, these in vitro activation experiments revealedCima et al. 1645
of GCs already 3 h post anti-CD3 injection (Fig. 4 C). Sim-
ilarly, the costimulatory effect of corticosterone on TCR-
induced CD69 expression in vitro was clearly evident after
3 h (Fig. 6 C). Taking into account that T cell activation in
vivo will first have to initiate the synthesis and release of
GCs by epithelial cells, which then act back on the modula-
tion of the T cell activation, this costimulatory feedback
loop via GCs has to be considered extremely fast and cannot
be explained by gene induction. It is thus interesting to note
that the synthetic GC dexamethasone can augment TCR-
induced intracellular Ca2  release in a GR-dependent but
protein synthesis–independent manner (36). Since sustained
intracellular Ca2  release is required for proper T cell activa-
tion, this transcription-independent GR-mediated costimu-
lation may help to pass over a certain activation threshold.
Although the adrenal glands are small in size, they have
an enormous steroid-producing capacity. In response to
immunological and psychological stress, the adrenals may
release large amounts of GCs into the blood circulation and
affect immune responses systemically. Thus, adrenal-released
GCs act by definition as hormones. However, GCs can also
be released into the surrounding tissue and may thus act in a
paracrine manner. For example, the thymic epithelium has
been recently recognized as GC-producing tissue (12, 38,
39). Thymic GCs appear to act on thymic epithelium-asso-
ciated immature thymocytes and modulate their activation
in response to TCR cross-linking. Using a GR antisense-
targeted transgenic mouse, Ashwell and colleagues have
found that locally produced GCs enhance positive selection
of thymocytes (14, 40). Although this finding supports our
own results, demonstrating a costimulatory role of GCs in
mature T cell activation, this predicted role of GCs in thy-
mic negative selection has been recently questioned and
thus remains controversial (13, 15, 16)
Apart from the thymus, the results reported here repre-
sent the first demonstration of extraadrenal GC synthesis.
Although the expression of steroidogenic enzymes has also
been detected in other organs, such as brain, skin, and vas-
cular tissue (for review see reference 41), reports on GC
synthesis are sparse so far. We have found that the intestinal
mucosa is capable of synthesizing and releasing considerable
amounts of GCs that are likely to regulate immune effector
cells in the close neighborhood. Although it has been tech-
nically very difficult to demonstrate a regulatory role for in-
testinal GCs due to the lack of tissue-specific inhibition of
GC synthesis, our results strongly support the notion that
in situ–produced GCs exhibit a regulatory activity on in-
testinal T cells that are in close contact with the GC-pro-
ducing epithelial cells, i.e., IELs and PPLs. Various reports
have shown that these intestinal T cells, in contrast to pe-
ripheral T cells, fail to be strongly activated ex vivo and
only proliferate weakly in response to mitogenic stimuli
(42–45). This almost anergic behavior in response to acti-
vation signals has been considered an important adaptation
to the delicate local environment. It is possible that in vivo
local GC synthesis may both inhibit and enhance intestinal
T cell activation, depending on the mode of activation and
the requirement for APCs. Thus, activation of intestinal T
cells may cause the induction of GC synthesis by neighbor-
ing epithelial cells, resulting in a locally restricted regulation
of intestinal immune responses. Since the release of GCs
appears to be dependent on the activation of intestinal T
cells, and in situ–produced GCs may only act within a lim-
ited area, it is likely that this GC-mediated costimulation of
T cells remains locally confined.
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